Related Experiment Video
Updated: Nov 19, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.8K
Is asthma a risk factor for COVID-19? Are phenotypes important?
Xavier Muñoz1,2,3, Florencia Pilia1, Iñigo Ojanguren1,2
1Servei de Pneumologia Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
ERJ Open Research
|February 2, 2021
Summary
Asthma does not increase COVID-19 risk. Most asthma patients studied had a non-T2 type, suggesting this asthma subtype may not be a significant factor in COVID-19 development.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- Asthma is a common chronic respiratory disease.
- The relationship between asthma and COVID-19 risk has been a subject of ongoing research.
- Understanding specific asthma phenotypes' impact on COVID-19 is crucial.
Purpose of the Study:
- To investigate whether asthma is a risk factor for developing COVID-19.
- To examine the role of different asthma phenotypes in COVID-19 susceptibility.
Main Methods:
- Retrospective analysis of patient data.
- Comparison of COVID-19 incidence in asthma patients versus a control group.
- Phenotyping of asthma patients (T2 vs. non-T2).
Main Results:
- Asthma was not identified as a risk factor for COVID-19 development.
- The majority of asthma patients included in the study exhibited a non-T2 asthma phenotype.
- No significant difference in COVID-19 rates was observed between asthma patients and controls.
Conclusions:
- The findings support the notion that asthma, particularly the non-T2 phenotype, does not elevate the risk of contracting COVID-19.
- Further research may be needed to explore potential links between T2-high asthma and COVID-19 outcomes.
Related Concept Videos
01:29Asthma-I: Introduction
3.0K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
01:20Asthma: Pathogenesis and Management
971
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
971
01:26Asthma-II: Pathophysiology and Classification
3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
01:24Asthma-III: Symptoms and Complications
2.9K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.9K
01:30Asthma-IV: Diagnostic and Management
2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K